3 hours Equities Analysts Set Expectations for XENE FY2026 EarningsMarketBeat
Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) – Research analysts at Leerink Partnrs lowered their FY2026 EPS estimates for shares of Xenon Pharmaceuticals in a report released on Tuesday, October 15th. Leerink Partnrs analyst M. Goodman no…
Earnings · Nasdaq 100 · Pharmaceuticals · Science
X